Agalsidase Beta BS I.V. Infusion 5mg [JCR] (アガルシダーゼ ベータBS点滴静注5mg「JCR」)

Land: Japan

Sprache: Englisch

Quelle: すりの適正使用協議会 RAD-AR Council, Japan

Kaufe es jetzt

Gebrauchsinformation Gebrauchsinformation (PIL)
01-10-2022

Wirkstoff:

Agalsidase beta (genetical recombination) [agalsidase beta biosimilar 1]

Verfügbar ab:

Sumitomo Pharma Co.,Ltd.

INN (Internationale Bezeichnung):

Agalsidase beta (genetical recombination) [agalsidase beta biosimilar 1]

Darreichungsform:

Injection

Gebrauchsinformation

                                Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 10/2022
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
AGALSIDASE BETA BS I.V. INFUSION 5MG [JCR]
ACTIVE INGREDIENT:
Agalsidase beta (genetical recombination) [agalsidase
beta biosimilar 1]
DOSAGE FORM:
Injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine supplements the human enzyme alfa-galactosidase.
It is usually used to treat Fabry disease.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
           
to be written by a healthcare
professional
))
・In general, this medicine is administered by intravenous drip
infusion every two weeks.
・The treatment period with this medicine depends on your symptoms.
PRECAUTIONS WHILE TAKING THIS MEDICINE
POSSIBLE ADVERSE REACTIONS TO THIS MEDICINE
The most commonly reported adverse reactions include chills, fever and
cough. If any of these
symptoms occur, consult with your doctor or pharmacist.
THE SYMPTOMS DESCRIBED BELOW ARE RARELY SEEN AS INITIAL SYMPTOMS OF
THE ADVERSE REACTIONS INDICATED
IN BRACKETS. IF ANY OF THESE SYMPTOMS OCCUR, STOP TAKING THIS MEDICINE
AND SEE
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Suchen Sie nach Benachrichtigungen zu diesem Produkt